Nevertheless, the effects of PI3K pathway inhibition (alone or combined with MEK inhibition) on CRC cell growth are profoundly influenced by the presence of fibroblast-derived soluble factors or direct cell-to-cell contact, particularly in PTEN-competent cells. The gene discussed is PIK3CD; the disease is colorectal carcinoma.